Joseph W LaPlume insider trades
Open-market stock purchases and sales by Joseph W LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc, from SEC Form 4 filings since Feb 22, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +70%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | — |
| May 31, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $42.5K |
| May 30, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $134K |
| May 29, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | $950K |
| May 27, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $29K |
| May 26, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $39K |
| Mar 3, 2026 | CRL Charles River Laboratories International, Inc | Bought | $4.4K |
| Jan 30, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | — |
| Jan 30, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $370K |
Companies traded
- CRL Charles River Laboratories International, Inc: 1 buy, 73 sales, last Aug 10, 2026